The Valley Desk

NCT07725796 · Interventional trial

A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

Overall registry status Recruiting

Phase 1

Conditions Bladder (Urothelial, Transitional Cell) Cancer, NMIBC, Non-Muscle Invasive Bladder Carcinoma, Non-muscle Invasive Bladder Cancer (NMIBC), Urothelial Carcinoma Bladder, Urothelial Carcinoma Recurrent, Urothelial Carcinoma in Situ, Urothelial Carcinoma of the Urinary Bladder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov